Polygenic risk scores as a marker for epilepsy risk across lifetime and after unspecified seizure events.
Autor: | Heyne HO; Hasso Plattner Institute for Digital Engineering, University of Potsdam, Germany.; Hasso Plattner Institute, Mount Sinai School of Medicine, NY, US.; Finnish Institute for Molecular Medicine (FIMM), University of Helsinki, Helsinki, Finland.; Program for Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Pajuste FD; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.; Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia., Wanner J; Hasso Plattner Institute for Digital Engineering, University of Potsdam, Germany.; Finnish Institute for Molecular Medicine (FIMM), University of Helsinki, Helsinki, Finland., Onwuchekwa JID; Hasso Plattner Institute for Digital Engineering, University of Potsdam, Germany.; Faculty of Life Sciences, University of Siegen, Germany., Mägi R; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.; Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia., Palotie A; Finnish Institute for Molecular Medicine (FIMM), University of Helsinki, Helsinki, Finland.; Program for Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Kälviainen R; Kuopio Epilepsy Center, Neurocenter, Kuopio University Hospital, Member of ERN EpiCARE, Kuopio, Finland.; Institute of Clinical Medicine, School of Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland., Daly MJ; Finnish Institute for Molecular Medicine (FIMM), University of Helsinki, Helsinki, Finland.; Program for Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | MedRxiv : the preprint server for health sciences [medRxiv] 2023 Nov 27. Date of Electronic Publication: 2023 Nov 27. |
DOI: | 10.1101/2023.11.27.23297542 |
Abstrakt: | A diagnosis of epilepsy has significant consequences for an individual but is often challenging in clinical practice. Novel biomarkers are thus greatly needed. Here, we investigated how common genetic factors (epilepsy polygenic risk scores, [PRSs]) influence epilepsy risk in detailed longitudinal electronic health records (EHRs) of > 360k Finns spanning up to 50 years of individuals' lifetimes. Individuals with a high genetic generalized epilepsy PRS (PRS Competing Interests: Competing interests M.J.D. is a founder of Maze Therapeutics. |
Databáze: | MEDLINE |
Externí odkaz: |